Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmaserve North West is a specialist contract development and manufacturing organization (CDMO) based in the United Kingdom, focusing on respiratory and intranasal drug delivery. The company provides a comprehensive range of services including formulation development, analytical testing, and commercial-scale manufacturing for pressurized metered-dose inhalers (pMDIs), dry powder inhalers (DPIs), and nasal sprays. Following its acquisition by Vectura Group in 2021, the company has integrated its expertise in aerosol technology to support global pharmaceutical clients. Their facilities are GMP-compliant and equipped to handle complex inhalation product requirements from clinical trials through to commercial launch.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmaserve North West.